Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts

被引:116
作者
Fedele, M
Berlingieri, MT
Scala, S
Chiariotti, L
Viglietto, G
Rippel, V
Bullerdiek, J
Santoro, M
Fusco, A
机构
[1] Univ Reggio Calabria, Fac Med & Chirurg Catanzaro, Dipartimento Med Sperimentale & Clin, I-88100 Catanzaro, Italy
[2] Ist Nazl Tumori, Fdn Senatore Pascale, I-80131 Naples, Italy
[3] Univ Naples Federico II, Fac Med & Chirurg Napoli, CNR,Ctr Endocrinol & Oncol Sperimentale, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy
[4] Univ Bremen, Ctr Human Genet & Genet, Bremen, Germany
关键词
lipoma; chromatin; oncogene; tumor;
D O I
10.1038/sj.onc.1201952
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Overexpression of the high mobility group I (HMGI) proteins is often associated with the malignant phenotype. Moreover, many benign human tumors, mainly of mesenchymal origin, are characterized by rearrangements of the HMGI-C gene. In most cases, HMGI-C alterations involve breaks within the third intron of the gene resulting in aberrant transcripts carrying exons from 1-3, which encode the three DNA binding domains, fused to ectopic sequences. Here, we show that the expression of a truncated form of HMGI-C protein carrying only the three DNA-binding domains, or of a fusion protein carrying the three DNA-binding domains of HMGI-C and the LIM domains of the lipoma preferred partner gene (LPP) protein, causes malignant transformation of NIH3T3 cells. The unrearranged wildtype HMGI-C cDNA did not exert any transforming activity. These findings indicate that rearranged forms of HMGI-C play a role in cell transformation.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 36 条
[1]  
ASHAR HR, 1995, CELL, V82, P57
[2]  
BERLINGIERI MT, 1995, MOL CELL BIOL, V15, P1545
[3]   An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12 [J].
Bol, S ;
Wanschura, S ;
Thode, B ;
Deichert, U ;
VandeVen, WJM ;
Bartnitzke, S ;
Bullerdiek, J .
CANCER GENETICS AND CYTOGENETICS, 1996, 90 (01) :88-90
[4]  
CHAN KY, 1995, NUCLEIC ACIDS RES, V21, P4262
[5]  
Chiappetta G, 1996, ONCOGENE, V13, P2439
[6]  
CHIAPPETTA G, 1995, ONCOGENE, V10, P1307
[7]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[8]   MULTIPLE CLOSELY-LINKED NFAT-OCTAMER AND HMG I(Y) BINDING-SITES ARE PART OF THE INTERLEUKIN-4 PROMOTER [J].
CHUVPILO, S ;
SCHOMBERG, C ;
GERWIG, R ;
HEINFLING, A ;
REEVES, R ;
GRUMMT, F ;
SERFLING, E .
NUCLEIC ACIDS RESEARCH, 1993, 21 (24) :5694-5704
[9]   ERBB-2 IS A POTENT ONCOGENE WHEN OVEREXPRESSED IN NIH/3T3 CELLS [J].
DIFIORE, PP ;
PIERCE, JH ;
KRAUS, MH ;
SEGATTO, O ;
KING, CR ;
AARONSON, SA .
SCIENCE, 1987, 237 (4811) :178-182
[10]   MECHANISMS OF TRANSCRIPTIONAL SYNERGISM BETWEEN DISTINCT VIRUS-INDUCIBLE ENHANCER ELEMENTS [J].
DU, W ;
THANOS, D ;
MANIATIS, T .
CELL, 1993, 74 (05) :887-898